Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

2020-03-24 10:05

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

BioResearch is following new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic, published by The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA). Please click below link for details.

Go back

News

2021-12-24 11:53

Phase I study finished

Our site has just succesfully finished clinical stage of phase I (two parts) study with JAK kinase inhibitors.

Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers

In BRG we are just starting Study for Healthy People with an Immune Drug - Part B. The aim of the following clinical trial...

2021-03-22 14:37

COVID-19 Vaccine AstraZeneca® – conclusion of EMA review of usage safety in reference to the thromboembolic events following vaccination

The European Medicines Agency’s (EMA) Pharmacovigilance...

2020-12-22 15:14

Merry Christmas and Happy New Year

Let the magical night of Christmas Eve bring peace and joy. Let every moment of Christmas live with its own beauty, and bestows the New Year with prosperity and happiness.

2020-11-05 14:10

COVID -19 Antigen Tests:

On 31^st of October 2020, the Chief Sanitary Inspectorate confirmed that the antigen cassette tests are the same basis for determining the SARS-CoV-2 ...